Among the highlights of WCLC are final overall survival (OS) data from AstraZeneca's FLAURA 2 study of EGFR inhibitor Tagrisso (osimertinib) given in combination with chemotherapy as a first-line ...
Andrew Barth Feldman stars as Oliver through November 1, 2025. Darren Criss returns on November 5, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback